Topiramate Capsule, Extended Release
Pricing Report NDC 69680-177-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Topiramate (NDC 69680-177-30) is $2.66170 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Vitruvias Therapeutics, Inc., this medication is distributed in a 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.66170
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
30 EA
Estimated Package Price
$79.85
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
69680-177-30
Description
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2025, the NADAC wholesale price for (NDC ) has moved within a range of $2.66170 to $3.82643 per EA. Over this 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.6617 - $3.8264
Market Volatility
43.76% Variance
Latest Trend
5.78%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $2.66170 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $2.82494 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $3.11590 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $3.34001 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 18, 2026 $3.57623 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 21, 2026 $3.64550 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 17, 2025 $3.67347 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 19, 2025 $3.70165 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Oct 22, 2025 $3.71562 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Sep 17, 2025 $3.79147 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 20, 2025 $3.82643 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 23, 2025 $3.82013 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 09, 2025 $3.71654 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026